{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:29:36Z","timestamp":1791836976267,"version":"4.3.4"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>In 2016 brain invasion was added as a standalone diagnostic criterion for Grade 2 meningiomas in the WHO Classification of Brain Tumors. The aim of this study was to compare the incidence and distribution of meningiomas, and agreement, between the 2007 and 2016 WHO criteria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>All cases of intracranial meningiomas diagnosed between 2007 and 2020 at a tertiary care academic hospital were identified. The incidence of each meningioma grade in the WHO 2007 and WHO 2016 cohorts were compared. Additionally, each case in the 2007 cohort was re-graded according to the WHO 2016 criteria to determine the intra-class correlation (ICC) between criteria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 814 cases, 532 (65.4%) were in the 2007 WHO cohort and 282 (34.6%) were in the 2016 WHO cohort. There were no differences in the distribution of meningioma grades between cohorts (P = .11). Incidence rates were: 75.0% vs. 75.2% for Grade 1, 22.7% vs. 24.5% for Grade 2, and 2.3% vs. 0.4% for Grade 3, for the 2007 and 2016 cohorts, respectively. Upon re-grading, 21 cases (3.9%) were changed. ICC between original and revised grade was 0.92 (95% CI: 0.91\u20130.93). Amongst Grade 2 meningiomas with brain invasion, 75.8% had three or more atypical histologic features or an elevated mitotic index.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Including brain invasion as a standalone diagnostic criterion for Grade 2 meningiomas had minimal impact on the incidence of specific meningioma grade tumors. There is strong agreement between the 2007 and 2016 WHO criteria, likely due to cosegregation of grade elevating features.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/neuonc\/noac032","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T12:29:34Z","timestamp":1643977774000},"page":"1524-1532","source":"Crossref","is-referenced-by-count":27,"title":["The impact of brain invasion criteria on the incidence and distribution of WHO grade 1, 2, and 3 meningiomas"],"prefix":"10.1093","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5553-346X","authenticated-orcid":false,"given":"Alexander D","family":"Rebchuk","sequence":"first","affiliation":[{"name":"Division of Neurosurgery, University of British Columbia , Vancouver, British Columbia , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley M","family":"Chaharyn","sequence":"additional","affiliation":[{"name":"Division of Neuropathology, University of British Columbia , Vancouver, British Columbia , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armaghan","family":"Alam","sequence":"additional","affiliation":[{"name":"MD Undergraduate Program, Faculty of Medicine, University of British Columbia , Vancouver, British Columbia , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5803-4455","authenticated-orcid":false,"given":"Celine D","family":"Hounjet","sequence":"additional","affiliation":[{"name":"MD Undergraduate Program, Faculty of Medicine, University of British Columbia , Vancouver, British Columbia , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Gooderham","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, University of British Columbia , Vancouver, British Columbia , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8514-9861","authenticated-orcid":false,"given":"Stephen","family":"Yip","sequence":"additional","affiliation":[{"name":"Division of Neuropathology, University of British Columbia , Vancouver, British Columbia , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Makarenko","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, University of British Columbia , Vancouver, British Columbia , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"issue":"suppl_5","key":"2022090114012199700_CIT0001","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/nox158","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010\u20132014","volume":"19","author":"Ostrom","year":"2017","journal-title":"Neuro Oncol."},{"issue":"6","key":"2022090114012199700_CIT0002","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"3","key":"2022090114012199700_CIT0003","doi-asserted-by":"crossref","first-page":"kab035","DOI":"10.1093\/jncics\/pkab035","article-title":"Incidence of benign meningiomas in the United States: current and future trends","volume":"5","author":"Bhala","year":"2021","journal-title":"JNCI Cancer Spectr."},{"issue":"3","key":"2022090114012199700_CIT0004","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-010-0342-2","article-title":"Pathological classification and molecular genetics of meningiomas","volume":"99","author":"Mawrin","year":"2010","journal-title":"J Neurooncol."},{"key":"2022090114012199700_CIT0005","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","author":"Louis","journal-title":"Neuro Oncol."},{"issue":"2","key":"2022090114012199700_CIT0006","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol."},{"issue":"3","key":"2022090114012199700_CIT0007","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jnen\/61.3.215","article-title":"The WHO classification of tumors of the nervous system","volume":"61","author":"Kleihues","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"2022090114012199700_CIT0008","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/978-3-642-84988-6_2","article-title":"Histological classification of tumours of the central nervous system","volume-title":"Histological Typing of Tumours of the Central Nervous System","author":"Kleihues","year":"1993"},{"issue":"3","key":"2022090114012199700_CIT0009","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1227\/01.NEU.0000170980.47582.A5","article-title":"Diagnosis and treatment of atypical and anaplastic meningiomas: a review","volume":"57","author":"Modha","year":"2005","journal-title":"Neurosurgery"},{"issue":"9","key":"2022090114012199700_CIT0010","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1470-2045(16)30321-7","article-title":"EANO guidelines for the diagnosis and treatment of meningiomas","volume":"17","author":"Goldbrunner","year":"2016","journal-title":"Lancet Oncol."},{"issue":"3","key":"2022090114012199700_CIT0011","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/14737175.2018.1429920","article-title":"Current treatment options for meningioma","volume":"18","author":"Apra","year":"2018","journal-title":"Expert Rev Neurother."},{"issue":"1","key":"2022090114012199700_CIT0012","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3171\/2014.7.JNS131644","article-title":"Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review","volume":"122","author":"Rogers","year":"2015","journal-title":"J Neurosurg."},{"issue":"3","key":"2022090114012199700_CIT0013","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/2015.1.FOCUS14757","article-title":"An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomas","volume":"38","author":"Sun","year":"2015","journal-title":"Neurosurg Focus."},{"issue":"2","key":"2022090114012199700_CIT0014","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2990.2004.00621.x","article-title":"The accuracy of meningioma grading: a 10-year retrospective audit","volume":"31","author":"Willis","year":"2005","journal-title":"Neuropathol Appl Neurobiol."},{"issue":"12","key":"2022090114012199700_CIT0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11910-020-01084-w","article-title":"A practical overview on the molecular biology of meningioma","volume":"20","author":"Delgado-L\u00f3pez","year":"2020","journal-title":"Curr Neurol Neurosci Rep."},{"issue":"10","key":"2022090114012199700_CIT0016","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/neuonc\/nox071","article-title":"Brain invasion in meningiomas\u2014clinical considerations and impact of neuropathological evaluation: a systematic review","volume":"19","author":"Brokinkel","year":"2017","journal-title":"Neuro Oncol."},{"key":"2022090114012199700_CIT0017","first-page":"8","article-title":"The definition and role of brain invasion in meningioma grading: still controversial after all these years","volume":"2","author":"Perry","year":"2021","journal-title":"Free Neuropathology."},{"issue":"12","key":"2022090114012199700_CIT0018","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/neuonc\/nox101","article-title":"Diagnostic challenges in meningioma","volume":"19","author":"Nowosielski","year":"2017","journal-title":"Neuro Oncol."},{"issue":"Suppl 1","key":"2022090114012199700_CIT0019","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/neuonc\/noy178","article-title":"Molecular and translational advances in meningiomas","volume":"21","author":"Suppiah","year":"2019","journal-title":"Neuro Oncol."},{"key":"2022090114012199700_CIT0020","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.wneu.2016.06.055","article-title":"Brain invasion in meningiomas: incidence and correlations with clinical variables and prognosis","volume":"93","author":"Spille","year":"2016","journal-title":"World Neurosur."},{"issue":"4","key":"2022090114012199700_CIT0021","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1227\/NEU.0000000000000461","article-title":"Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection","volume":"75","author":"Sun","year":"2014","journal-title":"Neurosurgery"},{"issue":"4","key":"2022090114012199700_CIT0022","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1227\/NEU.0000000000000462","article-title":"Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection","volume":"75","author":"Sun","year":"2014","journal-title":"Neurosurgery"},{"issue":"4","key":"2022090114012199700_CIT0023","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/FOC-07\/10\/E3","article-title":"Review of meningioma histopathology","volume":"23","author":"Commins","year":"2007","journal-title":"Neurosurg Focus."},{"issue":"5","key":"2022090114012199700_CIT0024","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol."},{"issue":"1","key":"2022090114012199700_CIT0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3171\/2015.1.JNS142228","article-title":"Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes","volume":"124","author":"Marciscano","year":"2016","journal-title":"J Neurosurg."},{"issue":"(1)","key":"2022090114012199700_CIT0026","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0959-8049(14)70660-4","article-title":"534 Expression of c-MET in invasive meningioma","volume":"49","author":"Yun","year":"2014","journal-title":"Eur J Cancer."},{"issue":"1","key":"2022090114012199700_CIT0027","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13293-020-00291-x","article-title":"Sex differences in cancer mechanisms","volume":"11","author":"Rubin","year":"2020","journal-title":"Biol Sex Differ."},{"issue":"3","key":"2022090114012199700_CIT0028","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1158\/1055-9965.EPI-07-0725","article-title":"Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology Consortium","volume":"17","author":"Davis","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"4","key":"2022090114012199700_CIT0029","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/neuonc\/nov247","article-title":"Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539","volume":"18","author":"Rogers","year":"2016","journal-title":"Neuro Oncol."},{"issue":"7874","key":"2022090114012199700_CIT0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","article-title":"A clinically applicable integrative molecular classification of meningiomas","volume":"597","author":"Nassiri","year":"2021","journal-title":"Nature."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noac032\/42827212\/noac032.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/24\/9\/1524\/45639262\/noac032.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/24\/9\/1524\/45639262\/noac032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T15:02:58Z","timestamp":1662044578000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/24\/9\/1524\/6525422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,2,9]]},"published-print":{"date-parts":[[2022,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noac032","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,1]]},"published":{"date-parts":[[2022,2,9]]}}}